Capital World Investors »

Caris Life Sciences shares owned by Capital World Investors

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Capital World Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 1.2M 17.88
2025-06-30 $27M 1000k 26.72

More positions owned by Capital World Investors

Broadcom (AVGO)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Philip Morris International (PM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Amazon (AMZN)
Amgen (AMGN)
Canadian Natural Resources (CNQ)

View all positions for Capital World Investors

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
J. H. Whitney Equity Partners VI
FMR
Coatue Management
T. Rowe Price Investment Management
Braidwell
PointState Capital
BlackRock
Neuberger Berman Group
Vanguard Portfolio Management
Vanguard Capital Management
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"
Duquesne Family Office

View all funds holding Caris Life Sciences